Dr. Everett has become the program leader at Johns Hopkins in pediatric biomarker discovery, with a focus on neonatal brain injury and pulmonary hypertension. This includes both protein and metabolic indicators of diagnosis and outcomes.

He is the principal investigator (PI) or co-PI on multiple NIH- funded R01 studies. Active studies as PI include: NICHD R01 HD086058, "Adult Biomarkers in Neonatal Brain Injury and Development", NHLBI R01HL150070, "Role of IGF axis in pulmonary hypertension" and Children's Heart Foundation "Role of cyclohexanone toxicity in mediating congenital cardiac surgical outcomes". Co-investigator on NINDS R01 NS106292 "Biomarkers of Brain Injury in Critically-Ill Children on Extracorporeal Membrane Oxygenation (ECMO)", NINDS 1 U01 NS114144 "Blood test to aid treatment decisions for perinatal asphyxiation", NICHD 1R01HD100540 "Renal Anhydramnios Fetal Therapy (RAFT) Trial", NHLBI "The Hemodynamic and Metabolic Effects of Advanced Circulatory Support for Resuscitation" and NHLBI "IKDR-PREVAIL".